Search (686 total)

Search Instructions:

* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.

Record Type	Thumbnail	Subject	Date Published	Description
Item	Risk of COVID-19 in health-care workers in Denmark: an observational cohort study	Research	2020-08-03	Health-care workers are thought to be highly exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We aimed to investigate the prevalence of antibodies against SARS-CoV-2 in health-care workers and the proportion of seroconverted health-care workers with previous… Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
Item	Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care	Infection Control	2020-07-29	The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in Wuhan, China in late 2019, and its resulting coronavirus disease, COVID-19, was declared a pandemic by the World Health Organization on March 11, 2020. The rapid global spread of COVID-19 represents perhaps the most…
Item	Outcomes from an infectious disease physician-guided evaluation of hospitalized persons under investigation for COVID-19 at a large US academic medical center	Research	2020-08-24	We describe an approach to the evaluation and isolation of hospitalized persons under investigation (PUIs) for COVID-19 at a large U.S. academic medical center. Only a small proportion (2.9%) of PUIs with one or more repeat SARS-CoV-2 nucleic acid tests (NATs) after a negative NAT were diagnosed…
Item	Remdesivir for the Treatment of Covid-19 — Final Report	Research	2020-11-05	We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.A response to this article was published:Dolin, Raphael, and Martin S. Hirsch. 2020. "Remdesivir — An…
Item	Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19	Research	2020-11-19	Hydroxychloroquine and chloroquine have been proposed as treatments for coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from uncontrolled studies and small, randomized trials.
Item	Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results	Research	2020-12-02	World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a — in patients hospitalized with coronavirus disease 2019 (Covid-19).
Item	Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial	Research	2021-02-03	A vaccine against COVID-19 is urgently needed for older adults, in whom morbidity and mortality due to the disease are increased. We aimed to assess the safety, tolerability, and immunogenicity of a candidate COVID-19 vaccine, CoronaVac, containing inactivated SARS-CoV-2, in adults aged 60 years and…
Item	The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study	Research	2021-01-05	Outpatient coronavirus disease 2019 (COVID-19) has been insufficiently characterized. To determine the progression of disease and determinants of hospitalization, we conducted a prospective cohort study.
Item	Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19	Research	2021-02-25	The efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear.
Item	Dexamethasone in Hospitalized Patients with Covid-19	Research	2021-02-25	Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death.